Answer
Type 1 diabetes, previously known as juvenile diabetes or insulin-dependent diabetes, is the primary target of Banting's insulin research. It is an autoimmune disease where the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas, leading to an absolute deficiency of insulin.